Effectiveness factor and diffusion limitations in collagen gel modules containing HepG2 cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 2, 2011, Pages 119-129

  Corstorphine, Lindsay ^a   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Collagen; Diffusion; Effectiveness factor; HepG2 cells; Module; Necrotic core

Indexed keywords

CELL ENGINEERING; CELLS; CYTOLOGY; MASS TRANSFER; OXYGEN; TISSUE; TISSUE ENGINEERING;

CELL DENSITY; COLLAGEN GELS; DIFFUSION LIMITATIONS; EFFECTIVENESS FACTOR; ENGINEERED TISSUES; HEP-G2 CELLS; MODULE; NECROTIC CORE; TISSUES ENGINEERINGS; VASCULATURE;

COLLAGEN;

COLLAGEN GEL; OXYGEN;

ARTICLE; BIOMIMETICS; CALCULATION; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIFFUSION; HUMAN; HUMAN TISSUE; OXYGEN TRANSPORT; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; VASCULARIZATION;

EID: 79251500696     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.296     Document Type: Article

References (31)

1. 2 in alginate gel beads entrapping hepatocytes. Biotechnol Lett 22(10): 865-870.
2. Avgoustiniatos ES, Colton CK. 1997; Design considerations in immunoisolation. In Principles of Tissue Engineering, Lanza RP, Langer R, Chick WL (eds). Academic Press: Austin, TX; 333-346.
3. Carmeliet P, Jain RK. 2000; Angiogenesis in cancer and other diseases. Nature 407(6801): 249-257.
4. Chang HN, Moo-Young M. 1988; Estimation of oxygen penetration depth in immobilized cells. Appl Microbiol Biotechnol 29(2-3): 107-112.
5. Chen JP, Yu SC, Hsu BR, et al. 2003; Loofa sponge as a scaffold for the culture of human hepatocyte cell line. Biotechnol Prog 19(2): 522-527.
6. Cho CH, Park J, Nagrath D, et al. 2007; Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng 97(1): 188-199.
7. Churchill SW. 1977; A generalized expression for the effectiveness factor of porous catalyst pellets. AIChE J 23(2): 208-210.
8. Dalili M, Chau PC. 1987; Intraparticle diffusional effects in immobilized cell particles. Appl Microbiol Biotechnol 26(6): 500-506.
9. Do D. 1984; Enzyme immobilization in porous solid supports-penetration of immobilized enzyme. Biotechnol Bioeng 26(9): 1032-1937.
10. Fournier RL. 1998; Basic Transport Phenomena in Biomedical Engineering. Taylor & Francis: Philadelphia, PA.
11. Fukuda J, Okamura K, Nakazawa K, et al. 2003; Efficacy of a polyurethane foam/spheroid artificial liver by using human hepatoblastoma cell line (Hep G2). Cell Transpl 12(1): 51-58.
12. Graven KK, Troxler RF, Kornfeld H, et al. 1994; Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 269(39): 24446-24453.
13. Hay PD, Veitch AR, Smith MD, et al. 2000; Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. Artif Organs 24(4): 278-288.
14. Hongo T, Kajikawa M, Ishida S, et al. 2005; Three-dimensional high-density culture of HepG2 cells in a 5 ml radial-flow bioreactor for construction of artificial liver. J Biosci Bioeng 99(3): 237-244.
15. Jasmund I, Langsch A, Simmoteit R, et al. 2002; Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol Prog 18(4): 839-846.
16. Karel SF, Libicki SB and Robertson CR. 1985; The immobilization of whole cells: engineering principles. Chem Eng Sci 40: 1321-1354.
17. Kaully T, Kaufman-Francis K, Lesman A, et al. 2009; Vascularization-the conduit to viable engineered tissues. Tissue Eng B Rev 15(2): 159-169.
18. Leclerc E, Sakai Y and Fujii T. 2004; Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes. Biotechnol Prog 20(3): 750-755.
19. McGuigan AP, Sefton MV. 2006; Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci USA 103(31): 11461-11466.
20. McGuigan AP, Sefton MV. 2007a; Design and fabrication of sub-mm-sized modules containing encapsulated cells for modular tissue engineering. Tissue Eng 13(5): 1069-1078.
21. McGuigan AP, Sefton MV. 2007b; Design criteria for a modular tissue-engineered construct. Tissue Eng 13(5): 1079-1089.
22. McGuigan AP, Sefton MV. 2008; The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules. Biomaterials 29(16): 2453-2463.
23. Mishra A, Starly B. 2009; Real-time in vitro measurement of oxygen uptake rates for HEPG2 liver cells encapsulated in alginate matrices. Microfluid Nanofluidics 6(3): 373-381.
24. Rotem A, Toner M, Tompkins RG, et al. 1992; Oxygen uptake rates in cultured rat hepatocytes. Biotechnol Bioeng 40: 1286-1291.
25. Said HM, Polat B, Hagemann C, et al. 2009; Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in vitro. BMC Res Notes 2: 8.
26. Shatford RA, Nyberg SL, Meier SJ, et al. 1992; Hepatocyte function in a hollow fibre bioreactor: a potential bioartificial liver. J Surg Res 53(6): 549-557.
27. Smith MD, Smirthwaite AD, Cairns DE, et al. 1996; Techniques for measurement of oxygen consumption rates of hepatocytes during attachment and post-attachment. Int J Artif Organs 19(1): 36-44.
28. Verma P, Verma V, Ray P, et al. 2007; Formation and characterization of three-dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications. In Vitro Cell Dev Biol Anim 43(10): 328-337.
29. Watanabe H, Matsuyama T and Yamamoto H. 2001; Preparation of immobilized enzyme gel particles using an electrostatic atomization technique. Biochem Eng J 8(2): 171-174.
30. Werner A, Duvar S, Muthing J, et al. 2000; Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng 68(1): 59-70.
31. Yamashita Y, Shimada M, Ijima H, et al. 2002; Hybrid-artificial liver support system. Surgery 131(1 suppl): S334-340.